Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 22 Breast Neoplasms 21 Polycystic Ovary Syndrome 12 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 10 Lung Neoplasms 8 Endometrial Neoplasms 7 Pancreatic Neoplasms 6 Neoplasms 6 Glioblastoma 5 Rectal Neoplasms 4 Melanoma 4 Lymphoma, Large B-Cell, Diffuse 4 Insulin Resistance 4 Adenocarcinoma of Lung 4 Adenocarcinoma 4 Uterine Cervical Neoplasms 3 Leukoplakia, Oral 3 Urinary Bladder Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Obesity 2 Neoplasm Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2 Hyperandrogenism 2 Esophageal Neoplasms 2 Erythroplasia 2 Endometrial Hyperplasia 2 Diabetes Mellitus 2 Colonic Neoplasms 2

Interventions

Temozolomide 6 Capecitabine 4 Everolimus 3 Thalidomide 2 Sunitinib 2 Streptozocin 2 Octreotide 2 Injections 2 Fluorouracil 2 surufatinib 1 sargramostim 1 recombinant interferon alpha 2b-like protein 1 nimotuzumab 1 motesanib diphosphate 1 montanide ISA 51 1 lutetium Lu 177 dotatate 1 incomplete Freund's adjuvant 1 ibrutinib 1 ganitumab 1 cabozantinib 1 belzutifan 1 batifiban 1 atezolizumab 1 abemaciclib 1 Tegafur 1 Specimen Handling 1 PM 01183 1 Metformin 1 Melphalan 1 Magnetic Resonance Spectroscopy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Adenoma, Islet Cell × Metformin × Clear all

NCT02294006 2021-09-09

MetNET1

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Adenoma, Islet Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡